Grantable
Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China Grant · THE PFIZER FOUNDATION INC
up to $110,000
Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China Grant Status: ACTIVE Funder: Pfizer, Inc. Amount: Up to US $110,000 Last Updated: November 25, 2025 Summary This study, supported by Pfiz…
Welcome to Grantable
Sign in to start building your grant-ready profile
or
We'll send you a one-time verification code. No password needed. By signing in you agree to our Terms of Service and Privacy Policy.